Inhibition of hepatic azo-reductase and aromatic hydroxylase by radiopharmaceuticals containing tin
- 1 September 1983
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 18 (3) , 269-272
- https://doi.org/10.1016/0378-4274(83)90105-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effect of stannous fluoride and sodium fluoride on hepatic mixed-function oxidase activities in the ratToxicology and Applied Pharmacology, 1981
- Effect of tin compounds on activity of 5-aminolevulinate dehydratase in bloodBiochemical and Biophysical Research Communications, 1978
- Regulation of cytochrome P‐450‐dependent microsomal drug‐metabolizing enzymes by nickel, cobalt, and ironClinical Pharmacology & Therapeutics, 1977
- DIFFERENCES IN THE OXIDATIVE METABOLISM OF DRUGS BY LIVER MICROSOMESThe Japanese Journal of Pharmacology, 1969
- Influence of several drugs on the in vivo and in vitro activity of mammalian hepatic azo-reductaseCanadian Journal of Biochemistry, 1968
- The Carbon Monoxide-binding Pigment of Liver MicrosomesJournal of Biological Chemistry, 1964
- ENZYMATIC REDUCTION OF PRONTOSIL AND OTHER AZO DYES1957